Clinical Trial Update: Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials evaluating sodium oxybate for spasmodic dysphonia and voice tremor have completed, with results posted on 2025-04-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasmodic Dysphonia
• Voice Tremor

Drugs mentioned

• Xyrem (Sodium Oxybate)

Snippet

Sponsor: Kristina Simonyan | Conditions: Spasmodic Dysphonia, Voice Tremor | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-04-04